15 results
8-K
EX-99.1
PASG
Passage Bio Inc
13 Nov 23
Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
7:00am
, as a result of our reductions in workforce.
Net Loss: Net loss was $27.1 million, or a net loss of $0.49 per basic and diluted share, for the quarter ended
8-K
dva 46ybd
20 Jul 23
Departure of Directors or Certain Officers
7:00am
8-K
EX-99.1
ug4sd3yzwzexjpn6 t2
10 Nov 22
Passage Bio Reports Third Quarter 2022 Financial Results And Provides Business Updates
7:03am
8-K
EX-99.1
y4r9rvivkt1 1r
16 May 22
Passage Bio Reports First Quarter 2022 Financial Results and Provides Recent Business Highlights
7:15am
8-K
d8uarglvb8d w2w2
15 Mar 22
Other Events
7:10am
S-8
EX-99.1
e2jpvvbo4mgoy2i96e
19 Jul 21
Registration of securities for employees
8:01am
S-1/A
EX-10.3
ipwebukctcrf5bl464p
18 Feb 20
IPO registration (amended)
6:13am
- Prev
- 1
- Next